Functional deficiencies of sulfite oxidase: Differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia

Johnson JL, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. Childs B, Kinzler KW, Vogelstein B, Assoc. editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 3163–77.

Schwarz, 2005, Molybdenum cofactor biosynthesis and deficiency, Cell Mol Life Sci, 62, 2792, 10.1007/s00018-005-5269-y

Johnson, 1989, Molybdenum cofactor biosynthesis in humans. Identification of two complementation groups of cofactor-deficient patients and preliminary characterization of a diffusible molybdopterin precursor, J Clin Invest, 83, 897, 10.1172/JCI113974

Johnson, 2002, Isolated sulfite oxidase deficiency: identification of 12 novel SUOX mutations in 10 patients, Hum Mutat, 20, 74, 10.1002/humu.9038

Leimkühler, 2005, Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abolishes the binding ability of molybdopterin synthase, Hum Genet, 117, 565, 10.1007/s00439-005-1341-9

Ichida, 2006, A Turkish case with molybdenum cofactor deficiency, Nucleosides Nucleotides Nucleic Acids, 25, 1087, 10.1080/15257770600894022

Touati, 2000, Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement, J Inherit Metab Dis, 23, 45, 10.1023/A:1005646813492

Boles, 1993, Short-term response to dietary therapy in molybdenum cofactor deficiency, Ann Neurol, 34, 742, 10.1002/ana.410340520

Graf, 1998, Ahomocysteinemia in molybdenum cofactor deficiency, Neurology, 51, 860, 10.1212/WNL.51.3.860

Kishikawa, 2002, The peak height ratio of S-sulfonated transthyretin and other oxidized isoforms as a marker for molybdenum cofactor deficiency, measured by electrospray ionization mass spectrometry, Biochim Biophys Acta, 1588, 135, 10.1016/S0925-4439(02)00156-4

Salman, 2002, New insights into the neuropathogenesis of molybdenum cofactor deficiency, Can J Neurol Sci, 29, 91, 10.1017/S0317167100001803

Olney, 1975, Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency, J Neuropathol Exp Neurol, 34, 167, 10.1097/00005072-197503000-00005

Zhang, 2004, A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase, J Biol Chem, 279, 43035, 10.1074/jbc.M402759200

Tan, 2005, Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature, Pediatrics, 116, 757, 10.1542/peds.2004-1897

Hobson, 2005, Isolated sulphite oxidase deficiency mimics the features of hypoxic ischaemic encephalopathy, Eur J Pediatr, 164, 655, 10.1007/s00431-005-1729-5

Hoffmann, 2007, Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency, J Child Neurol, 22, 1214, 10.1177/0883073807306260

Eichler, 2006, Proton magnetic resonance spectroscopy and diffusion-weighted imaging in isolated sulfite oxidase deficiency, J Child Neurol, 21, 801, 10.1177/08830738060210090601

n Moorsel, 1991, Infantile isolated sulphite oxidase deficiency: report of a case with negative sulphite test and normal sulphate excretion, Eur J Pediatr, 150, 196, 10.1007/BF01963565

Simmonds, 1999, Diagnosis of molybdenum cofactor deficiency, Lancet, 353, 675, 10.1016/S0140-6736(05)75473-8

Duran, 1981, 2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate – a pitfall in the diagnosis of sulfite oxidase deficiency, Clin Chim Acta, 111, 47, 10.1016/0009-8981(81)90419-8

Sass, 2004, New approaches towards laboratory diagnosis of isolated sulphite oxidase deficiency, Ann Clin Biochem, 41, 157, 10.1258/000456304322880078

Lee, 2002, A novel mutation in neonatal isolated sulphite oxidase deficiency, Neuropediatrics, 33, 174, 10.1055/s-2002-34491

Chan, 2002, Infantile isolated sulphite oxidase deficiency in a Chinese family: a rare neurodegenerative disorder, Hong Kong Med J, 8, 279

Schwarz, 2004, Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli, Hum Mol Genet, 13, 1249, 10.1093/hmg/ddh136

Schwarz G, Veldman A, Santamaria-Araujo JA, Sollazo S, Pitt J, Yaplito-Lee J, et al. Successful treatment of molybdenum cofactor deficiency type A with cyclic pyranopterin monophosphate (cPMP). In: Abstract & poster, 23rd annual symposium of the Arbeitsgemeinschaft Pädiatrische Stoffwechselstörungen, Fulda, German, March 11– 13, 2009.